Table of Contents Author Guidelines Submit a Manuscript
Journal of Transplantation
Volume 2013, Article ID 761429, 17 pages
http://dx.doi.org/10.1155/2013/761429
Review Article

Dendritic Cell-Based Approaches for Therapeutic Immune Regulation in Solid-Organ Transplantation

1Department of Cardiology, Centre Hospitalier Universitaire Vaudois, 1011 Lausanne, Switzerland
2Molecular Cardiology Laboratory, Fondazione Cardiocentro Ticino, 6900 Lugano, Switzerland

Received 31 May 2013; Accepted 16 September 2013

Academic Editor: F. H. J. Claas

Copyright © 2013 Giuseppe Vassalli. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. K. J. Wood and R. Goto, “Mechanisms of rejection: current perspectives,” Transplantation, vol. 93, no. 1, pp. 1–10, 2012. View at Publisher · View at Google Scholar · View at Scopus
  2. K. J. Wood, A. Bushell, and J. Hester, “Regulatory immune cells in transplantation,” Nature Reviews Immunology, vol. 12, pp. 417–430, 2012. View at Google Scholar
  3. S. I. Alexander, N. Smith, D. Verran et al., “Chimerism and tolerance in a recipient of a deceased-donor liver transplant,” The New England Journal of Medicine, vol. 358, no. 4, pp. 369–374, 2008. View at Publisher · View at Google Scholar · View at Scopus
  4. L. J. West, “ABO-incompatible hearts for infant transplantation,” Current Opinion in Organ Transplantation, vol. 16, no. 5, pp. 548–554, 2011. View at Publisher · View at Google Scholar · View at Scopus
  5. M. Takatsuki, S. Uemoto, Y. Inomata et al., “Weaning of immunosuppression in living donor liver transplant recipients,” Transplantation, vol. 72, no. 3, pp. 449–454, 2001. View at Google Scholar · View at Scopus
  6. S. Strober, M. Dhillon, M. Schubert et al., “Acquired immune tolerance to cadaveric renal allografts. A study of three patients treated with total lymphoid irradiation,” The New England Journal of Medicine, vol. 321, no. 1, pp. 28–33, 1989. View at Google Scholar · View at Scopus
  7. T. Kawai, D. H. Sachs, M. Sykes, A. B. Cosimi, and Immune Tolerance Network, “HLA-mismatched renal transplantation without maintenance immunosuppression,” The New England Journal of Medicine, vol. 368, no. 19, pp. 1850–1852, 2013. View at Google Scholar
  8. J. D. Scandling, S. Busque, S. Dejbakhsh-Jones et al., “Tolerance and withdrawal of immunosuppressive drugs in patients given kidney and hematopoietic cell transplants,” American Journal of Transplantation, vol. 12, no. 5, pp. 1133–1145, 2012. View at Publisher · View at Google Scholar · View at Scopus
  9. J. Leventhal, M. Abecassis, J. Miller et al., “Tolerance induction in HLA disparate living donor kidney transplantation by donor stem cell infusion: durable chimerism predicts outcome,” Transplantation, vol. 95, no. 1, pp. 169–176, 2013. View at Google Scholar
  10. A. D. Salama, G. Remuzzi, W. E. Harmon, and M. H. Sayegh, “Challenges to achieving clinical transplantation tolerance,” Journal of Clinical Investigation, vol. 108, no. 7, pp. 943–948, 2001. View at Publisher · View at Google Scholar · View at Scopus
  11. R. E. Billingham, L. Brent, and P. B. Medawar, “‘Actively acquired tolerance’ of foreign cells,” Nature, vol. 172, no. 4379, pp. 603–606, 1953. View at Publisher · View at Google Scholar · View at Scopus
  12. B. M. Hall, M. E. Jelbart, and S. E. Dorsch, “Suppressor T cells in rats with prolonged cardiac allograft survival after treatment with cyclosporine,” Transplantation, vol. 37, no. 6, pp. 595–600, 1984. View at Google Scholar · View at Scopus
  13. K. J. Wood and S. Sakaguchi, “Regulatory T cells in transplantation tolerance,” Nature Reviews Immunology, vol. 3, no. 3, pp. 199–210, 2003. View at Publisher · View at Google Scholar · View at Scopus
  14. Y. Li, T. Koshiba, A. Yoshizawa et al., “Analyses of peripheral blood mononuclear cells in operational tolerance after pediatric living donor liver transplantation,” American Journal of Transplantation, vol. 4, no. 12, pp. 2118–2125, 2004. View at Publisher · View at Google Scholar · View at Scopus
  15. M. Martínez-Llordella, I. Puig-Pey, G. Orlando et al., “Multiparameter immune profiling of operational tolerance in liver transplantation,” American Journal of Transplantation, vol. 7, no. 2, pp. 309–319, 2007. View at Publisher · View at Google Scholar · View at Scopus
  16. S. Brouard, E. Mansfield, C. Braud et al., “Identification of a peripheral blood transcriptional biomarker panel associated with operational renal allograft tolerance,” Proceedings of the National Academy of Sciences of the United States of America, vol. 104, no. 39, pp. 15448–15453, 2007. View at Publisher · View at Google Scholar · View at Scopus
  17. K. A. Newell, A. Asare, A. D. Kirk et al., “Identification of a B cell signature associated with renal transplant tolerance in humans,” Journal of Clinical Investigation, vol. 120, no. 6, pp. 1836–1847, 2010. View at Publisher · View at Google Scholar · View at Scopus
  18. P. Sagoo, E. Perucha, B. Sawitzki et al., “Development of a cross-platform biomarker signature to detect renal transplant tolerance in humans,” Journal of Clinical Investigation, vol. 120, no. 6, pp. 1848–1861, 2010. View at Publisher · View at Google Scholar · View at Scopus
  19. C. Ohnmacht, A. Pullner, S. B. S. King et al., “Constitutive ablation of dendritic cells breaks self-tolerance of CD4 T cells and results in spontaneous fatal autoimmunity,” Journal of Experimental Medicine, vol. 206, no. 3, pp. 549–559, 2009. View at Publisher · View at Google Scholar · View at Scopus
  20. M. Hill, P. Thebault, M. Segovia et al., “Cell therapy with autologous tolerogenic dendritic cells induces allograft tolerance through interferon-gamma and Epstein-Barr virus-induced gene 3,” American Journal of Transplantation, vol. 11, no. 10, pp. 2036–2045, 2011. View at Publisher · View at Google Scholar · View at Scopus
  21. H. Torres-Aguilar, S. R. Aguilar-Ruiz, G. González-Pérez et al., “Tolerogenic dendritic cells generated with different immunosuppressive cytokines induce antigen-specific anergy and regulatory properties in memory CD4+ T cells,” Journal of Immunology, vol. 184, no. 4, pp. 1765–1775, 2010. View at Publisher · View at Google Scholar · View at Scopus
  22. K. Liu and M. C. Nussenzweig, “Origin and development of dendritic cells,” Immunological Reviews, vol. 234, no. 1, pp. 45–54, 2010. View at Publisher · View at Google Scholar · View at Scopus
  23. R. M. Steinman and J. Idoyaga, “Features of the dendritic cell lineage,” Immunological Reviews, vol. 234, no. 1, pp. 5–17, 2010. View at Publisher · View at Google Scholar · View at Scopus
  24. S. Laffont and F. Powrie, “Immunology: dendritic-cell genealogy,” Nature, vol. 462, no. 7274, pp. 732–733, 2009. View at Publisher · View at Google Scholar · View at Scopus
  25. K. Crozat, R. Guiton, M. Guilliams et al., “Comparative genomics as a tool to reveal functional equivalences between human and mouse dendritic cell subsets,” Immunological Reviews, vol. 234, no. 1, pp. 177–198, 2010. View at Publisher · View at Google Scholar · View at Scopus
  26. N. M. Rogers, J. S. Isenberg, and A. W. Thomson, “Plasmacytoid dendritic cells: no longer an enigma and now key to transplant tolerance?” American Journal of Transplantation, vol. 13, no. 5, pp. 1125–1133, 2013. View at Google Scholar
  27. W. Cao and L. Bover, “Signaling and ligand interaction of ILT7: receptor-mediated regulatory mechanisms for plasmacytoid dendritic cells,” Immunological Reviews, vol. 234, no. 1, pp. 163–176, 2010. View at Publisher · View at Google Scholar · View at Scopus
  28. A. W. Thomson, R. Fischer, H. R. Turnquist, and T. Taner, “Use of rapamycin in the induction of tolerogenic dendritic cells,” Handbook of Experimental Pharmacology, vol. 188, pp. 215–232, 2009. View at Publisher · View at Google Scholar · View at Scopus
  29. R. T. Fischer, H. R. Turnquist, Z. Wang, D. Beer-Stolz, and A. W. Thomson, “Rapamycin-conditioned, alloantigen-pulsed myeloid dendritic cells present donor MHC class I/peptide via the semi-direct pathway and inhibit survival of antigen-specific CD8+ T cells in vitro and in vivo,” Transplant Immunology, vol. 25, no. 1, pp. 20–26, 2011. View at Publisher · View at Google Scholar · View at Scopus
  30. C. Macedo, H. Turquist, D. Metes, and A. W. Thomson, “Immunoregulatory properties of rapamycin-conditioned monocyte-derived dendritic cells and their role in transplantation,” Transplantation Research, vol. 1, no. 1, article 16, 2012. View at Google Scholar
  31. L. Li, L. Huang, H. Ye et al., “Dendritic cells tolerized with adenosine A2AR agonist attenuate acute kidney injury,” Journal of Clinical Investigation, vol. 122, no. 11, pp. 3931–3942, 2012. View at Google Scholar
  32. T. Nikolic and B. O. Roep, “Regulatory multitasking of tolerogenic dendritic cells—lessons taken from vitamin d3-treated tolerogenic dendritic cells,” Frontiers in Immunology, vol. 4, article 113, 2013. View at Google Scholar
  33. S. J. Divito, Z. Wang, W. J. Shufesky et al., “Endogenous dendritic cells mediate the effects of intravenously injected therapeutic immunosuppressive dendritic cells in transplantation,” Blood, vol. 116, no. 15, pp. 2694–2705, 2010. View at Publisher · View at Google Scholar · View at Scopus
  34. Z. Wang, S. J. Divito, W. J. Shufesky et al., “Dendritic cell therapies in transplantation revisited: deletion of recipient DCs deters the effect of therapeutic DCs,” American Journal of Transplantation, vol. 12, no. 6, pp. 1398–1408, 2012. View at Publisher · View at Google Scholar · View at Scopus
  35. A. Montecalvo, A. T. Larregina, W. J. Shufesky et al., “Mechanism of transfer of functional microRNAs between mouse dendritic cells via exosomes,” Blood, vol. 119, no. 3, pp. 756–766, 2012. View at Publisher · View at Google Scholar · View at Scopus
  36. X. Li, J. J. Li, J. Y. Yang et al., “Tolerance induction by exosomes from immature dendritic cells and rapamycin in a mouse cardiac allograft model,” PLoS ONE, vol. 7, no. 8, Article ID e44045, 2012. View at Google Scholar
  37. N. Giannoukakis, B. Phillips, D. Finegold, J. Harnaha, and M. Trucco, “Phase I, (safety) study of autologous tolerogenic dendritic cells in type 1 diabetic patients,” Diabetes Care, vol. 34, pp. 2026–2032, 2011. View at Google Scholar
  38. C. M. Hilkens and J. D. Isaacs, “Tolerogenic dendritic cell therapy for rheumatoid arthritis: where are we now?” Clinical and Experimental Immunology, vol. 172, no. 2, pp. 148–157, 2013. View at Google Scholar
  39. A. Moreau, E. Varey, L. Bouchet-Delbos, and M. C. Cuturi, “Cell therapy using tolerogenic dendritic cells in transplantation,” Transplantation Research, vol. 1, article 13, 2012. View at Google Scholar
  40. J. Banchereau, F. Briere, C. Caux et al., “Immunobiology of dendritic cells,” Annual Review of Immunology, vol. 18, pp. 767–811, 2000. View at Publisher · View at Google Scholar · View at Scopus
  41. D. Hawiger, K. Inaba, Y. Dorsett et al., “Dendritic cells induce peripheral T cell unresponsiveness under steady state conditions in vivo,” Journal of Experimental Medicine, vol. 194, no. 6, pp. 769–779, 2001. View at Publisher · View at Google Scholar · View at Scopus
  42. G. Süss and K. Shortman, “A subclass of dendritic cells kills CD4 T cells via Fas/Fas-ligand-induced apoptosis,” Journal of Experimental Medicine, vol. 183, no. 4, pp. 1789–1796, 1996. View at Google Scholar · View at Scopus
  43. R. A. Maldonado and U. H. von Andrian, “How tolerogenic dendritic cells induce regulatory T cells,” Advances in Immunology, vol. 108, pp. 111–165, 2010. View at Publisher · View at Google Scholar · View at Scopus
  44. A. E. Morelli and A. W. Thomson, “Tolerogenic dendritic cells and the quest for transplant tolerance,” Nature Reviews Immunology, vol. 7, no. 8, pp. 610–621, 2007. View at Publisher · View at Google Scholar · View at Scopus
  45. K. Pletinckx, A. Döhler, V. Pavlovic, and M. B. Lutz, “Role of dendritic cell maturity/costimulation for generation, homeostasis, and suppressive activity of regulatory T cells,” Frontiers in Immunology, vol. 2, article 39, 2011. View at Google Scholar
  46. M. Ezzelarab and A. W. Thomson, “Tolerogenic dendritic cells and their role in transplantation,” Seminars in Immunology, vol. 23, no. 4, pp. 252–263, 2011. View at Publisher · View at Google Scholar · View at Scopus
  47. T. G. Berger, H. Schulze-Koops, M. Schäfer, E. Müller, and M. B. Lutz, “Immature and maturation-resistant human dendritic cells generated from bone marrow require two stimulations to induce T cell anergy in vitro,” PLoS ONE, vol. 4, no. 8, Article ID e6645, 2009. View at Publisher · View at Google Scholar · View at Scopus
  48. H. Ueno, E. Klechevsky, R. Morita et al., “Dendritic cell subsets in health and disease,” Immunological Reviews, vol. 219, no. 1, pp. 118–142, 2007. View at Publisher · View at Google Scholar · View at Scopus
  49. B. Pulendran, H. Tang, and T. L. Denning, “Division of labor, plasticity, and crosstalk between dendritic cell subsets,” Current Opinion in Immunology, vol. 20, no. 1, pp. 61–67, 2008. View at Publisher · View at Google Scholar · View at Scopus
  50. K. R. R. Siddiqui and F. Powrie, “CD103+ GALT DCs promote Foxp3+ regulatory T cells,” Mucosal Immunology, vol. 1, no. 1, pp. S34–S38, 2008. View at Publisher · View at Google Scholar · View at Scopus
  51. K. Shortman and W. R. Heath, “The CD8+ dendritic cell subset,” Immunological Reviews, vol. 234, no. 1, pp. 18–31, 2010. View at Publisher · View at Google Scholar · View at Scopus
  52. C. Coquerelle and M. Moser, “DC subsets in positive and negative regulation of immunity,” Immunological Reviews, vol. 234, no. 1, pp. 317–334, 2010. View at Publisher · View at Google Scholar · View at Scopus
  53. S. Milling, U. Yrlid, V. Cerovic, and G. MacPherson, “Subsets of migrating intestinal dendritic cells,” Immunological Reviews, vol. 234, no. 1, pp. 259–267, 2010. View at Publisher · View at Google Scholar · View at Scopus
  54. M. Swiecki and M. Colonna, “Unraveling the functions of plasmacytoid dendritic cells during viral infections, autoimmunity, and tolerance,” Immunological Reviews, vol. 234, no. 1, pp. 142–162, 2010. View at Publisher · View at Google Scholar · View at Scopus
  55. D. Vremec, M. Zorbas, R. Scollay et al., “The surface phenotype of dendritic cells purified from mouse thymus and spleen: investigation of the CD8 expression by a subpopulation of dendritic cells,” Journal of Experimental Medicine, vol. 176, no. 1, pp. 47–58, 1992. View at Publisher · View at Google Scholar · View at Scopus
  56. X. Ju, G. Clark, and D. N. J. Hart, “Review of human DC subtypes,” Methods in Molecular Biology, vol. 595, pp. 3–20, 2010. View at Google Scholar · View at Scopus
  57. A. G. Jegalian, F. Facchetti, and E. S. Jaffe, “Plasmacytoid dendritic cells physiologic roles and pathologic states,” Advances in Anatomic Pathology, vol. 16, no. 6, pp. 392–404, 2009. View at Publisher · View at Google Scholar · View at Scopus
  58. C. Varol, L. Landsman, D. K. Fogg et al., “Monocytes give rise to mucosal, but not splenic, conventional dendritic cells,” Journal of Experimental Medicine, vol. 204, no. 1, pp. 171–180, 2007. View at Publisher · View at Google Scholar · View at Scopus
  59. M. A. Schmid, D. Kingston, S. Boddupalli, and M. G. Manz, “Instructive cytokine signals in dendritic cell lineage commitment,” Immunological Reviews, vol. 234, no. 1, pp. 32–44, 2010. View at Publisher · View at Google Scholar · View at Scopus
  60. J. Helft, F. Ginhoux, M. Bogunovic, and M. Merad, “Origin and functional heterogeneity of non-lymphoid tissue dendritic cells in mice,” Immunological Reviews, vol. 234, no. 1, pp. 55–75, 2010. View at Publisher · View at Google Scholar · View at Scopus
  61. L. Bar-On and S. Jung, “Defining dendritic cells by conditional and constitutive cell ablation,” Immunological Reviews, vol. 234, no. 1, pp. 76–89, 2010. View at Publisher · View at Google Scholar · View at Scopus
  62. N. Romani, B. E. Clausen, and P. Stoitzner, “Langerhans cells and more: langerin-expressing dendritic cell subsets in the skin,” Immunological Reviews, vol. 234, no. 1, pp. 120–141, 2010. View at Publisher · View at Google Scholar · View at Scopus
  63. R. Maarten Egeler, A. G. S. Van Halteren, P. C. W. Hogendoorn, J. D. Laman, and P. J. M. Leenen, “Langerhans cell histiocytosis: fascinating dynamics of the dendritic cell-macrophage lineage,” Immunological Reviews, vol. 234, no. 1, pp. 213–232, 2010. View at Publisher · View at Google Scholar · View at Scopus
  64. S.-Y. Chang and M.-N. Kweon, “Langerin-expressing dendritic cells in gut-associated lymphoid tissues,” Immunological Reviews, vol. 234, no. 1, pp. 233–246, 2010. View at Publisher · View at Google Scholar · View at Scopus
  65. H. Tezuka and T. Ohteki, “Regulation of intestinal homeostasis by dendritic cells,” Immunological Reviews, vol. 234, no. 1, pp. 247–258, 2010. View at Publisher · View at Google Scholar · View at Scopus
  66. M.-L. Del Rio, G. Bernhardt, J.-I. Rodriguez-Barbosa, and R. Förster, “Development and functional specialization of CD103+ dendritic cells,” Immunological Reviews, vol. 234, no. 1, pp. 268–281, 2010. View at Publisher · View at Google Scholar · View at Scopus
  67. A. M. Kerrigan and G. D. Brown, “Syk-coupled C-type lectin receptors that mediate cellular activation via single tyrosine based activation motifs,” Immunological Reviews, vol. 234, no. 1, pp. 335–352, 2010. View at Publisher · View at Google Scholar · View at Scopus
  68. B. León, M. López-Bravo, and C. Ardavín, “Monocyte-derived dendritic cells formed at the infection site control the induction of protective T helper 1 responses against leishmania,” Immunity, vol. 26, no. 4, pp. 519–531, 2007. View at Publisher · View at Google Scholar · View at Scopus
  69. N. V. Serbina, T. P. Salazar-Mather, C. A. Biron, W. A. Kuziel, and E. G. Pamer, “TNF/iNOS-producing dendritic cells mediate innate immune defense against bacterial infection,” Immunity, vol. 19, no. 1, pp. 59–70, 2003. View at Publisher · View at Google Scholar · View at Scopus
  70. F. Sallusto, P. Schaerli, P. Loetscher et al., “Rapid and coordinated switch in chemokine receptor expression during dendritic cell maturation,” European Journal of Immunology, vol. 28, pp. 2760–2769, 1998. View at Google Scholar
  71. F. Re and J. L. Strominger, “Heterogeneity of TLR-induced responses in dendritic cells: from innate to adaptive immunity,” Immunobiology, vol. 209, no. 1-2, pp. 191–198, 2004. View at Publisher · View at Google Scholar · View at Scopus
  72. E. Meylan and J. Tschopp, “Toll-like receptors and RNA helicases: two parallel ways to trigger antiviral responses,” Molecular Cell, vol. 22, no. 5, pp. 561–569, 2006. View at Publisher · View at Google Scholar · View at Scopus
  73. R. M. Steinman, G. Kaplan, M. D. Witmer, and Z. A. Cohn, “Identification of a novel cell type in peripheral lymphoid organs of mice. V. Purification of spleen dendritic cells, new surface markers, and maintenance in vitro,” Journal of Experimental Medicine, vol. 149, no. 1, pp. 1–16, 1979. View at Google Scholar · View at Scopus
  74. W. C. Van Voorhis, L. S. Hair, R. M. Steinman, and G. Kaplan, “Human dendritic cells. Enrichment and characterization from peripheral blood,” Journal of Experimental Medicine, vol. 155, no. 4, pp. 1172–1187, 1982. View at Google Scholar · View at Scopus
  75. Ö. Türeci, H. Bian, F. O. Nestle et al., “Cascades of transcriptional induction during dendritic cell maturation revealed by genome-wide expression analysis,” FASEB Journal, vol. 17, no. 8, pp. 836–847, 2003. View at Publisher · View at Google Scholar · View at Scopus
  76. D. McIlroy, S. Tanguy-Royer, N. Le Meur et al., “Profiling dendritic cell maturation with dedicated microarrays,” Journal of Leukocyte Biology, vol. 78, no. 3, pp. 794–803, 2005. View at Publisher · View at Google Scholar · View at Scopus
  77. M.-C. Dieu, B. Vanbervliet, A. Vicari et al., “Selective recruitment of immature and mature dendritic cells by distinct chemokines expressed in different anatomic sites,” Journal of Experimental Medicine, vol. 188, no. 2, pp. 373–386, 1998. View at Publisher · View at Google Scholar · View at Scopus
  78. A. Martín-Fontecha, S. Sebastiani, U. E. Höpken et al., “Regulation of dendritic cell migration to the draining lymph node: impact on T lymphocyte traffic and priming,” Journal of Experimental Medicine, vol. 198, no. 4, pp. 615–621, 2003. View at Publisher · View at Google Scholar · View at Scopus
  79. R. M. Steinman and Z. A. Cohn, “Identification of a novel cell type in peripheral lymphoid organs of mice. I. Morphology, quantitation, tissue distribution,” Journal of Experimental Medicine, vol. 137, pp. 1142–1162, 1973. View at Google Scholar · View at Scopus
  80. R. L. Lindquist, G. Shakhar, D. Dudziak et al., “Visualizing dendritic cell networks in vivo,” Nature Immunology, vol. 5, no. 12, pp. 1243–1250, 2004. View at Publisher · View at Google Scholar · View at Scopus
  81. K. Inaba, M. Inaba, M. Naito, and R. M. Steinman, “Dendritic cell progenitors phagocytose particulates, including Bacillus Calmette-Guerin organisms, and sensitize mice to mycobacterial antigens in vivo,” Journal of Experimental Medicine, vol. 178, no. 2, pp. 479–488, 1993. View at Google Scholar · View at Scopus
  82. F.-P. Huang, N. Platt, M. Wykes et al., “A discrete subpopulation of dendritic cells transports apoptotic intestinal epithelial cells to T cell areas of mesenteric lymph nodes,” Journal of Experimental Medicine, vol. 191, no. 3, pp. 435–443, 2000. View at Publisher · View at Google Scholar · View at Scopus
  83. W. R. Heath, G. T. Belz, G. M. N. Behrens et al., “Cross-presentation, dendritic cell subsets, and the generation of immunity to cellular antigens,” Immunological Reviews, vol. 199, pp. 9–26, 2004. View at Publisher · View at Google Scholar · View at Scopus
  84. D. Schmid, M. Pypaert, and C. Münz, “Antigen-loading compartments for major histocompatibility complex class ii molecules continuously receive input from autophagosomes,” Immunity, vol. 26, no. 1, pp. 79–92, 2007. View at Publisher · View at Google Scholar · View at Scopus
  85. K. Inaba, S. Turley, T. Iyoda et al., “The formation of immunogenic major histocompatibility complex class II-peptide ligands in lysosomal compartments of dendritic cells is regulated by inflammatory stimuli,” Journal of Experimental Medicine, vol. 191, no. 6, pp. 927–936, 2000. View at Publisher · View at Google Scholar · View at Scopus
  86. S. J. Turley, K. Inaba, W. S. Garrett et al., “Transport of peptide-MHC class II complexes in developing dendritic cells,” Science, vol. 288, no. 5465, pp. 522–527, 2000. View at Publisher · View at Google Scholar · View at Scopus
  87. A. Chow, D. Toomre, W. Garrett, and I. Mellman, “Dendritic cell maturation triggers retrograde MHC class II transport from lysosomes to the plasma membrane,” Nature, vol. 418, no. 6901, pp. 988–994, 2002. View at Publisher · View at Google Scholar · View at Scopus
  88. M. H. Sayegh and L. A. Turka, “Thr role of T-cell costimulatory activation pathways in transplant rejection,” The New England Journal of Medicine, vol. 338, no. 25, pp. 1813–1821, 1998. View at Publisher · View at Google Scholar · View at Scopus
  89. S. J. F. Cronin and J. M. Penninger, “From T-cell activation signals to signaling control of anti-cancer immunity,” Immunological Reviews, vol. 220, no. 1, pp. 151–168, 2007. View at Publisher · View at Google Scholar · View at Scopus
  90. H. Jonuleit, E. Schmitt, G. Schuler, J. Knop, and A. H. Enk, “Induction of interleukin 10-producing, nonproliferating CD4+ T cells with regulatory properties by repetitive stimulation with allogeneic immature human dendritic cells,” Journal of Experimental Medicine, vol. 192, no. 9, pp. 1213–1222, 2000. View at Publisher · View at Google Scholar · View at Scopus
  91. F. Fu, Y. Li, S. Qian et al., “Costimulatory molecule-deficient dendritic cell progenitors (MHC class II+, CD80(dim), CD86-) prolong cardiac allograft survival in nonimmunosuppressed recipients,” Transplantation, vol. 62, no. 5, pp. 659–665, 1996. View at Google Scholar · View at Scopus
  92. M. B. Lutz, R. M. Suri, M. Niimi et al., “Immature dendritic cells generated with low doses of GM-CSF in the absence of IL-4 are maturation resistant and prolong allograft survival in vivo,” European Journal of Immunology, vol. 30, pp. 1813–1822, 2000. View at Google Scholar
  93. P. J. O'Connell, W. Li, Z. Wang, S. M. Specht, A. J. Logar, and A. W. Thomson, “Immature and mature CD8α+ dendritic cells prolong the survival of vascularized heart allografts,” Journal of Immunology, vol. 168, no. 1, pp. 143–154, 2002. View at Google Scholar · View at Scopus
  94. D. L. Roelen, D. H. Schuurhuis, D. E. M. Van Den Boogaardt et al., “Prolongation of skin graft survival by modulation of the alloimmune response with alternatively activated dendritic cells,” Transplantation, vol. 76, no. 11, pp. 1608–1615, 2003. View at Publisher · View at Google Scholar · View at Scopus
  95. K. Sato, N. Yamashita, N. Yamashita, M. Baba, and T. Matsuyama, “Regulatory dendritic cells protect mice from murine acute graft-versus-host disease and leukemia relapse,” Immunity, vol. 18, no. 3, pp. 367–379, 2003. View at Publisher · View at Google Scholar · View at Scopus
  96. H. Pêche, B. Trinité, B. Martinet, and M. C. Cuturi, “Prolongation of heart allograft survival by immature dendritic cells generated from recipient type bone marrow progenitors,” American Journal of Transplantation, vol. 5, no. 2, pp. 255–267, 2005. View at Publisher · View at Google Scholar · View at Scopus
  97. C. Caux, C. Dezutter-Dambuyant, D. Schmit, and J. Banchereau, “GM-CSF and TNF-α cooperate in the generation of dendritic Langerhans cells,” Nature, vol. 360, no. 6401, pp. 258–261, 1992. View at Publisher · View at Google Scholar · View at Scopus
  98. M. Arpinati, C. L. Green, S. Heimfeld, J. E. Heuser, and C. Anasetti, “Granulocyte-colony stimulating factor mobilizes T helper 2-inducing dendritic cells,” Blood, vol. 95, no. 8, pp. 2484–2490, 2000. View at Google Scholar · View at Scopus
  99. K. Y. Vermaelen, I. Carro-Muino, B. N. Lambrecht, and R. A. Pauwels, “Specific migratory dendritic cells rapidly transport antigen from the airways to the thoracic lymph nodes,” Journal of Experimental Medicine, vol. 193, no. 1, pp. 51–60, 2001. View at Publisher · View at Google Scholar · View at Scopus
  100. I. Apostolou and H. Von Boehmer, “In vivo instruction of suppressor commitment in naive T cells,” Journal of Experimental Medicine, vol. 199, no. 10, pp. 1401–1408, 2004. View at Publisher · View at Google Scholar · View at Scopus
  101. M. Ostroukhova, C. Seguin-Devaux, T. B. Oriss et al., “Tolerance induced by inhaled antigen involves CD4+ T cells expressing membrane-bound TGF-β and FOXP3,” Journal of Clinical Investigation, vol. 114, no. 1, pp. 28–38, 2004. View at Publisher · View at Google Scholar · View at Scopus
  102. H. J. De Heer, H. Hammad, T. Soullié et al., “Essential role of lung plasmacytoid dendritic cells in preventing asthmatic reactions to harmless inhaled antigen,” Journal of Experimental Medicine, vol. 200, no. 1, pp. 89–98, 2004. View at Publisher · View at Google Scholar · View at Scopus
  103. K. Kretschmer, I. Apostolou, D. Hawiger, K. Khazaie, M. C. Nussenzweig, and H. von Boehmer, “Inducing and expanding regulatory T cell populations by foreign antigen,” Nature Immunology, vol. 6, no. 12, pp. 1219–1227, 2005. View at Publisher · View at Google Scholar · View at Scopus
  104. S. Yamazaki, K. Inaba, K. V. Tarbell, and R. M. Steinman, “Dendritic cells expand antigen-specific Foxp3+CD25+ CD4+ regulatory T cells including suppressors of alloreactivity,” Immunological Reviews, vol. 212, pp. 314–329, 2006. View at Publisher · View at Google Scholar · View at Scopus
  105. N. M. Tsuji and A. Kosaka, “Oral tolerance: intestinal homeostasis and antigen-specific regulatory T cells,” Trends in Immunology, vol. 29, no. 11, pp. 532–540, 2008. View at Publisher · View at Google Scholar · View at Scopus
  106. B. N. Lambrecht and H. Hammad, “Biology of lung dendritic cells at the origin of asthma,” Immunity, vol. 31, no. 3, pp. 412–424, 2009. View at Publisher · View at Google Scholar · View at Scopus
  107. T. Birnberg, L. Bar-On, A. Sapoznikov et al., “Lack of conventional dendritic cells is compatible with normal development and T cell homeostasis, but causes myeloid proliferative syndrome,” Immunity, vol. 29, no. 6, pp. 986–997, 2008. View at Publisher · View at Google Scholar · View at Scopus
  108. G. Darrasse-Jèze, S. Deroubaix, H. Mouquet et al., “Feedback control of regulatory T cell homeostasis by dendritic cells in vivo,” Journal of Experimental Medicine, vol. 206, no. 9, pp. 1853–1862, 2009. View at Publisher · View at Google Scholar · View at Scopus
  109. S. Paust and H. Cantor, “Regulatory T cells and autoimmune disease,” Immunological Reviews, vol. 204, pp. 195–207, 2005. View at Publisher · View at Google Scholar · View at Scopus
  110. Q. Tang and J. A. Bluestone, “The Foxp3+ regulatory T cell: a jack of all trades, master of regulation,” Nature Immunology, vol. 9, no. 3, pp. 239–244, 2008. View at Publisher · View at Google Scholar · View at Scopus
  111. D. A. A. Vignali, L. W. Collison, and C. J. Workman, “How regulatory T cells work,” Nature Reviews Immunology, vol. 8, no. 7, pp. 523–532, 2008. View at Publisher · View at Google Scholar · View at Scopus
  112. M. A. Travis, B. Reizis, A. C. Melton et al., “Loss of integrin αvβ8 on dendritic cells causes autoimmunity and colitis in mice,” Nature, vol. 449, no. 7160, pp. 361–365, 2007. View at Publisher · View at Google Scholar · View at Scopus
  113. Y. Laouar, T. Town, D. Jeng et al., “TGF-β signaling in dendritic cells is a prerequisite for the control of autoimmune encephalomyelitis,” Proceedings of the National Academy of Sciences of the United States of America, vol. 105, no. 31, pp. 10865–10870, 2008. View at Publisher · View at Google Scholar · View at Scopus
  114. J. A. Bluestone and A. K. Abbas, “Natural versus adaptive regulatory T cells,” Nature Reviews Immunology, vol. 3, no. 3, pp. 253–257, 2003. View at Publisher · View at Google Scholar · View at Scopus
  115. C.-W. J. Lio and C.-S. Hsieh, “A two-step process for thymic regulatory T cell development,” Immunity, vol. 28, no. 1, pp. 100–111, 2008. View at Publisher · View at Google Scholar · View at Scopus
  116. J. E. Mold, J. Michaëlsson, T. D. Burt et al., “Maternal alloantigens promote the development of tolerogenic fetal regulatory T cells in utero,” Science, vol. 322, no. 5907, pp. 1562–1565, 2008. View at Publisher · View at Google Scholar · View at Scopus
  117. J. M. Kim and A. Rudensky, “The role of the transcription factor Foxp3 in the development of regulatory T cells,” Immunological Reviews, vol. 212, pp. 86–98, 2006. View at Publisher · View at Google Scholar · View at Scopus
  118. M. V. Dhodapkar, R. M. Steinman, J. Krasovsky, C. Munz, and N. Bhardwaj, “Antigen-specific inhibition of effector T cell function in humans after injection of immature dendritic cells,” Journal of Experimental Medicine, vol. 193, no. 2, pp. 233–238, 2001. View at Publisher · View at Google Scholar · View at Scopus
  119. C. Reis E Sousa, “Dendritic cells in a mature age,” Nature Reviews Immunology, vol. 6, no. 6, pp. 476–483, 2006. View at Publisher · View at Google Scholar · View at Scopus
  120. R. Tisch, “Immunogenic versus tolerogenic dendritic cells: a matter of maturation,” International Reviews of Immunology, vol. 29, no. 2, pp. 111–118, 2010. View at Publisher · View at Google Scholar · View at Scopus
  121. L. Ohl, M. Mohaupt, N. Czeloth et al., “CCR7 governs skin dendritic cell migration under inflammatory and steady-state conditions,” Immunity, vol. 21, no. 2, pp. 279–288, 2004. View at Publisher · View at Google Scholar · View at Scopus
  122. G. Hintzen, L. Ohl, M.-L. Del Rio et al., “Induction of tolerance to innocuous inhaled antigen relies on a CCR7-dependent dendritic cell-mediated antigen transport to the bronchial lymph node,” Journal of Immunology, vol. 177, no. 10, pp. 7346–7354, 2006. View at Google Scholar · View at Scopus
  123. M. H. Jang, N. Sougawa, T. Tanaka et al., “CCR7 is critically important for migration of dendritic cells in intestinal lamina propria to mesenteric lymph nodes,” Journal of Immunology, vol. 176, no. 2, pp. 803–810, 2006. View at Google Scholar · View at Scopus
  124. T. Worbs, U. Bode, S. Yan et al., “Oral tolerance originates in the intestinal immune system and relies on antigen carriage by dendritic cells,” Journal of Experimental Medicine, vol. 203, no. 3, pp. 519–527, 2006. View at Publisher · View at Google Scholar · View at Scopus
  125. R. Förster, A. C. Davalos-Misslitz, and A. Rot, “CCR7 and its ligands: balancing immunity and tolerance,” Nature Reviews Immunology, vol. 8, no. 5, pp. 362–371, 2008. View at Publisher · View at Google Scholar · View at Scopus
  126. M. Cella, F. Facchetti, A. Lanzavecchia, and M. Colonna, “Plasmacytoid dendritic cells activated by influenza virus and CD40L drive a potent TH1 polarization,” Nature Immunology, vol. 1, no. 4, pp. 305–310, 2000. View at Google Scholar · View at Scopus
  127. H. Hadeiba, T. Sato, A. Habtezion, C. Oderup, J. Pan, and E. C. Butcher, “CCR9 expression defines tolerogenic plasmacytoid dendritic cells able to suppress acute graft-versus-host disease,” Nature Immunology, vol. 9, no. 11, pp. 1253–1260, 2008. View at Publisher · View at Google Scholar · View at Scopus
  128. D. Tokita, G. V. Mazariegos, A. F. Zahorchak et al., “High PD-L1/CD86 ratio on plasmacytoid dendritic cells correlates with elevated T-regulatory cells in liver transplant tolerance,” Transplantation, vol. 85, no. 3, pp. 369–377, 2008. View at Publisher · View at Google Scholar · View at Scopus
  129. M. Kool, M. Van Nimwegen, M. A. M. Willart et al., “An anti-inflammatory role for plasmacytoid dendritic cells in allergic airway inflammation,” Journal of Immunology, vol. 183, no. 2, pp. 1074–1082, 2009. View at Publisher · View at Google Scholar · View at Scopus
  130. Q. Tang and J. A. Bluestone, “Plasmacytoid DCs and Treg cells: casual acquaintance or monogamous relationship?” Nature Immunology, vol. 7, no. 6, pp. 551–553, 2006. View at Publisher · View at Google Scholar · View at Scopus
  131. J. C. Ochando, C. Homma, Y. Yang et al., “Alloantigen-presenting plasmacytoid dendritic cells mediate tolerance to vascularized grafts,” Nature Immunology, vol. 7, no. 6, pp. 652–662, 2006. View at Publisher · View at Google Scholar · View at Scopus
  132. M. Abe, Z. Wang, A. De Creus, and A. W. Thomson, “Plasmacytoid dendritic cell precursors induce allogeneic T-cell hyporesponsiveness and prolong heart graft survival,” American Journal of Transplantation, vol. 5, no. 8, pp. 1808–1819, 2005. View at Publisher · View at Google Scholar · View at Scopus
  133. M. Gilliet and Y.-J. Liu, “Generation of human CD8 T regulatory cells by CD40 ligand-activated plasmacytoid dendritic cells,” Journal of Experimental Medicine, vol. 195, no. 6, pp. 695–704, 2002. View at Publisher · View at Google Scholar · View at Scopus
  134. A. I. Proietto, S. Van Dommelen, P. Zhou et al., “Dendritic cells in the thymus contribute to T-regulatory cell induction,” Proceedings of the National Academy of Sciences of the United States of America, vol. 105, no. 50, pp. 19869–19874, 2008. View at Publisher · View at Google Scholar · View at Scopus
  135. N. Watanabe, Y.-H. Wang, H. K. Lee et al., “Hassall's corpuscles instruct dendritic cells to induce CD4+CD25+ regulatory T cells in human thymus,” Nature, vol. 436, no. 7054, pp. 1181–1185, 2005. View at Publisher · View at Google Scholar · View at Scopus
  136. G. Beriou, A. Moreau, and M. C. Cuturi, “Tolerogenic dendritic cells: applications for solid organ transplantation,” Current Opinion in Organ Transplantation, vol. 17, no. 1, pp. 42–47, 2012. View at Publisher · View at Google Scholar · View at Scopus
  137. A. W. Thomson, “Tolerogenic dendritic cells: all present and correct?” American Journal of Transplantation, vol. 10, no. 2, pp. 214–219, 2010. View at Publisher · View at Google Scholar · View at Scopus
  138. P. T. H. Coates, B. L. Colvin, H. Hackstein, and A. W. Thomson, “Manipulation of dendritic cells as an approach to improved outcomes in transplantation,” Expert Reviews in Molecular Medicine, vol. 4, no. 3, pp. 1–21, 2002. View at Google Scholar · View at Scopus
  139. P. T. H. Coates, B. L. Colvin, K. Kaneko, T. Taner, and A. W. Thomson, “Pharmacologic, biologic, and genetic engineering approaches to potentiation of donor-derived dendritic cell tolerogenicity,” Transplantation, vol. 75, no. 9, pp. 32S–36S, 2003. View at Google Scholar · View at Scopus
  140. H. Hackstein and A. W. Thomson, “Dendritic cells: emerging pharmacological targets of immunosuppressive drugs,” Nature Reviews Immunology, vol. 4, no. 1, pp. 24–34, 2004. View at Google Scholar · View at Scopus
  141. A. H. Enk, “Dendritic cells in tolerance induction,” Immunology Letters, vol. 99, no. 1, pp. 8–11, 2005. View at Publisher · View at Google Scholar · View at Scopus
  142. K. R. McCurry, B. L. Colvin, A. F. Zahorchak, and A. W. Thomson, “Regulatory dendritic cell therapy in organ transplantation,” Transplant International, vol. 19, no. 7, pp. 525–538, 2006. View at Publisher · View at Google Scholar · View at Scopus
  143. R. Schwartz and W. Dameshek, “Drug-induced immunological tolerance,” Nature, vol. 183, no. 4676, pp. 1682–1683, 1959. View at Publisher · View at Google Scholar · View at Scopus
  144. M. Moser, T. De Smedt, T. Sornasse et al., “Glucocorticoids down-regulate dendritic cell function in vitro and in vivo,” European Journal of Immunology, vol. 25, no. 10, pp. 2818–2824, 1995. View at Publisher · View at Google Scholar · View at Scopus
  145. L. Piemonti, P. Monti, P. Allavena et al., “Glucocorticoids affect human dendritic cell differentiation and maturation,” Journal of Immunology, vol. 162, no. 11, pp. 6473–6481, 1999. View at Google Scholar · View at Scopus
  146. N. Vanderheyde, V. Verhasselt, M. Goldman, and F. Willems, “Inhibition of human dendritic cell functions by methylprednisolone,” Transplantation, vol. 67, no. 10, pp. 1342–1347, 1999. View at Publisher · View at Google Scholar · View at Scopus
  147. M. K. Matyszak, S. Citterio, and M. Rescigno, “Differential effects of corticosteroids during different stages of dendritic cell maturation,” European Journal of Immunology, vol. 30, pp. 1233–1242, 2000. View at Google Scholar
  148. A. M. Woltman, J. W. de Fijter, S. W. Kamerling, L. C. Paul, M. R. Daha, and C. van Kooten, “The effect of calcineurin inhibitors and corticosteroids on the differentiation of human dendritic cells,” European Journal of Immunology, vol. 30, no. 7, pp. 1807–1812, 2000. View at Google Scholar
  149. A. E. Pedersen, E. G. W. Schmidt, M. Gad, S. S. Poulsen, and M. H. Claesson, “Dexamethasone/1α-25-dihydroxyvitamin D3-treated dendritic cells suppress colitis in the SCID T-cell transfer model,” Immunology, vol. 127, no. 3, pp. 354–364, 2009. View at Publisher · View at Google Scholar · View at Scopus
  150. M. Abe and A. W. Thomson, “Dexamethasone preferentially suppresses plasmacytoid dendritic cell differentiation and enhances their apoptotic death,” Clinical Immunology, vol. 118, no. 2-3, pp. 300–306, 2006. View at Publisher · View at Google Scholar · View at Scopus
  151. L. Piemonti, P. Monti, M. Sironi et al., “Vitamin D3 affects differentiation, maturation, and function of human monocyte-derived dendritic cells,” Journal of Immunology, vol. 164, no. 9, pp. 4443–4451, 2000. View at Google Scholar · View at Scopus
  152. M. D. Griffin, W. H. Lutz, V. A. Phan, L. A. Bachman, D. J. McKean, and R. Kumar, “Potent inhibition of dendritic cell differentiation and maturation by vitamin D analogs,” Biochemical and Biophysical Research Communications, vol. 270, no. 3, pp. 701–708, 2000. View at Publisher · View at Google Scholar · View at Scopus
  153. D. Raïch-Regué, L. Grau-Lopez, M. Naranjo-Gomez et al., “Stable antigen-specific T-cell hyporesponsiveness induced by tolerogenic dendritic cells from multiple sclerosis patients,” European Journal of Immunology, vol. 42, no. 3, pp. 771–782, 2012. View at Google Scholar
  154. R. A. Harry, A. E. Anderson, J. D. Isaacs, and C. M. U. Hilkens, “Generation and characterisation of therapeutic tolerogenic dendritic cells for rheumatoid arthritis,” Annals of the Rheumatic Diseases, vol. 69, no. 11, pp. 2042–2050, 2010. View at Publisher · View at Google Scholar · View at Scopus
  155. A. E. Anderson, B. L. Sayers, M. A. Haniffa et al., “Differential regulation of naïve and memory CD4+ T cells by alternatively activated dendritic cells,” Journal of Leukocyte Biology, vol. 84, no. 1, pp. 124–133, 2008. View at Publisher · View at Google Scholar · View at Scopus
  156. A. E. Anderson, D. J. Swan, B. L. Sayers et al., “LPS activation is required for migratory activity and antigen presentation by tolerogenic dendritic cells,” Journal of Leukocyte Biology, vol. 85, no. 2, pp. 243–250, 2009. View at Publisher · View at Google Scholar · View at Scopus
  157. K. Steinbrink, M. Wölfl, H. Jonuleit, J. Knop, and A. H. Enk, “Induction of tolerance by IL-10-treated dendritic cells,” Journal of Immunology, vol. 159, no. 10, pp. 4772–4780, 1997. View at Google Scholar · View at Scopus
  158. C. Buelens, F. Willems, A. Delvaux et al., “Interleukin-10 differentially regulates B7-1 (CD80) and B7-2 (CD86) expression on human peripheral blood dendritic cells,” European Journal of Immunology, vol. 25, no. 9, pp. 2668–2672, 1995. View at Publisher · View at Google Scholar · View at Scopus
  159. C. Buelens, V. Verhasselt, D. De Groote, K. Thielemans, M. Goldman, and F. Willems, “Human dendritic cell responses to lipopolysaccharide and CD40 ligation are differentially regulated by interleukin-10,” European Journal of Immunology, vol. 27, no. 8, pp. 1848–1852, 1997. View at Publisher · View at Google Scholar · View at Scopus
  160. K. Steinbrink, H. Jonuleit, G. Müller, G. Schuler, J. Knop, and A. H. Enk, “Interleukin-10-treated human dendritic cells induce a melanoma-antigen- specific anergy in CD8+ T cells resulting in a failure to lyse tumor cells,” Blood, vol. 93, no. 5, pp. 1634–1642, 1999. View at Google Scholar · View at Scopus
  161. K. Steinbrink, E. Graulich, S. Kubsch, J. Knop, and A. H. Enk, “CD4+ and CD8+ anergic T cells induced by interleukin-10-treated human dendritic cells display antigen-specific suppressor activity,” Blood, vol. 99, no. 7, pp. 2468–2476, 2002. View at Publisher · View at Google Scholar · View at Scopus
  162. A. F. Zahorchak, L. S. Kean, D. Tokita et al., “Infusion of stably immature monocyte-derived dendritic cells plus CTLA4Ig modulates alloimmune reactivity in rhesus macaques,” Transplantation, vol. 84, no. 2, pp. 196–206, 2007. View at Publisher · View at Google Scholar · View at Scopus
  163. S. Gregori, D. Tomasoni, V. Pacciani et al., “Differentiation of type 1 T regulatory cells (Tr1) by tolerogenic DC-10 requires the IL-10-dependent ILT4/HLA-G pathway,” Blood, vol. 116, no. 6, pp. 935–944, 2010. View at Publisher · View at Google Scholar · View at Scopus
  164. M. K. Levings, S. Gregori, E. Tresoldi, S. Cazzaniga, C. Bonini, and M. G. Roncarolo, “Differentiation of Tr1 cells by immature dendritic cells requires IL-10 but not CD25+CD4+ Tr cells,” Blood, vol. 105, no. 3, pp. 1162–1169, 2005. View at Publisher · View at Google Scholar · View at Scopus
  165. T. Takayama, A. E. Morelli, N. Onai et al., “Mammalian and viral IL-10 enhance C-C chemokine receptor 5 but down-regulate C-C chemokine receptor 7 expression by myeloid dendritic cells: impact on chemotactic responses and in vivo homing ability,” Journal of Immunology, vol. 166, no. 12, pp. 7136–7143, 2001. View at Google Scholar · View at Scopus
  166. V. Sordi, G. Bianchi, C. Buracchi et al., “Differential effects of immunosuppressive drugs on chemokine receptor CCR7 in human monocyte-derived dendritic cells: selective upregulation by rapamycin,” Transplantation, vol. 82, no. 6, pp. 826–834, 2006. View at Publisher · View at Google Scholar · View at Scopus
  167. Y.-R. Lee, I.-H. Yang, Y.-H. Lee et al., “Cyclosporin A and tacrolimus, but not rapamycin, inhibit MHC-restricted antigen presentation pathways in dendritic cells,” Blood, vol. 105, no. 10, pp. 3951–3955, 2005. View at Publisher · View at Google Scholar · View at Scopus
  168. H. Matsue, C. Yang, K. Matsue, D. Edelbaum, M. Mummert, and A. Takashima, “Contrasting impacts of immunosuppressive agents (rapamycin, FK506, cyclosporin A, and dexamethasone) on bidirectional dendritic cell-T cell interaction during antigen presentation,” Journal of Immunology, vol. 169, no. 7, pp. 3555–3564, 2002. View at Google Scholar · View at Scopus
  169. T. Chen, J. Guo, M. Yang et al., “Cyclosporin A impairs dendritic cell migration by regulating chemokine receptor expression and inhibiting cyclooxygenase-2 expression,” Blood, vol. 103, no. 2, pp. 413–421, 2004. View at Publisher · View at Google Scholar · View at Scopus
  170. A. Mehling, S. Grabbe, M. Voskort, T. Schwarz, T. A. Luger, and S. Beissert, “Mycophenolate mofetil impairs the maturation and function of murine dendritic cells,” Journal of Immunology, vol. 165, no. 5, pp. 2374–2381, 2000. View at Google Scholar · View at Scopus
  171. R. Matasic, A. B. Dietz, and S. Vuk-Pavlovic, “Cyclooxygenase-independent inhibition of dendritic cell maturation by aspirin,” Immunology, vol. 101, no. 1, pp. 53–60, 2000. View at Publisher · View at Google Scholar · View at Scopus
  172. H. Hackstein, A. E. Morelli, A. T. Larregina et al., “Aspirin inhibits in vitro maturation and in vivo immunostimulatory function of murine myeloid dendritic cells,” Journal of Immunology, vol. 166, no. 12, pp. 7053–7062, 2001. View at Google Scholar · View at Scopus
  173. M. Buckland, C. B. Jago, H. Fazekasova et al., “Aspirin-treated human DCs up-regulate ILT-3 and induce hyporesponsiveness and regulatory activity in responder T cells,” American Journal of Transplantation, vol. 6, no. 9, pp. 2046–2059, 2006. View at Publisher · View at Google Scholar · View at Scopus
  174. M. Buckland and G. Lombardi, “Aspirin and the induction of tolerance by dendritic cells,” Handbook of Experimental Pharmacology, vol. 188, pp. 197–213, 2009. View at Publisher · View at Google Scholar · View at Scopus
  175. M. A. Tepper, S. G. Nadler, J. M. Esselstyn, and K. G. Sterbenz, “Deoxyspergualin inhibits κ light chain expression in 70Z/3 pre-B cells by blocking lipopolysaccharide-induced NF-κb activation,” Journal of Immunology, vol. 155, no. 5, pp. 2427–2436, 1995. View at Google Scholar · View at Scopus
  176. M.-M. Tiao, L. Lu, R. Tao, L. Wang, J. J. Fung, and S. Qian, “Prolongation of cardiac allograft survival by systemic administration of immature recipient dendritic cells deficient in NF-κB activity,” Annals of Surgery, vol. 241, no. 3, pp. 497–505, 2005. View at Publisher · View at Google Scholar · View at Scopus
  177. A. Hernandez, M. Burger, B. B. Blomberg et al., “Inhibition of NF-κB during human dendritic cell differentiation generates anergy and regulatory T-cell activity for one but not two human leukocyte antigen DR mismatches,” Human Immunology, vol. 68, no. 9, pp. 715–729, 2007. View at Publisher · View at Google Scholar · View at Scopus
  178. W. Grotz, S. Siebig, M. Olschewski, C. W. Strey, and K. Peter, “Low-dose aspirin therapy is associated with improved allograft function and prolonged allograft survival after kidney transplantation,” Transplantation, vol. 77, no. 12, pp. 1848–1853, 2004. View at Publisher · View at Google Scholar · View at Scopus
  179. Z.-X. Zhang, L. Yang, K. J. Young, B. DuTemple, and L. Zhang, “Identification of a previously unknown antigen-specific regulatory T cell and its mechanism of suppression,” Nature Medicine, vol. 6, no. 7, pp. 782–789, 2000. View at Publisher · View at Google Scholar · View at Scopus
  180. B. Sawitzki, C. I. Kingsley, V. Oliveira, M. Karim, M. Herber, and K. J. Wood, “IFN-γ production by alloantigen-reactive regulatory T cells is important for their regulatory function in vivo,” Journal of Experimental Medicine, vol. 201, no. 12, pp. 1925–1935, 2005. View at Publisher · View at Google Scholar · View at Scopus
  181. L. Zhang and A. W. Thomson, “New partners for tolerogenic dendritic cells,” American Journal of Transplantation, vol. 11, no. 10, pp. 2003–2004, 2011. View at Publisher · View at Google Scholar · View at Scopus
  182. A. W. Thomson, H. R. Turnquist, and G. Raimondi, “Immunoregulatory functions of mTOR inhibition,” Nature Reviews Immunology, vol. 9, no. 5, pp. 324–337, 2009. View at Publisher · View at Google Scholar · View at Scopus
  183. T. Weichhart, G. Costantino, M. Poglitsch et al., “The TSC-mTOR signaling pathway regulates the innate inflammatory response,” Immunity, vol. 29, no. 4, pp. 565–577, 2008. View at Publisher · View at Google Scholar · View at Scopus
  184. H. R. Turnquist, G. Raimondi, A. F. Zahorchak, R. T. Fischer, Z. Wang, and A. W. Thomson, “Rapamycin-conditioned dendritic cells are poor stimulators of allogeneic CD4+ T cells, but enrich for antigen-specific Foxp3+ T regulatory cells and promote organ transplant tolerance,” Journal of Immunology, vol. 178, no. 11, pp. 7018–7031, 2007. View at Google Scholar · View at Scopus
  185. H. R. Turnquist, T. L. Sumpter, A. Tsung et al., “IL-1β-driven ST2L expression promotes maturation resistance in rapamycin-conditioned dendritic cells,” Journal of Immunology, vol. 181, no. 1, pp. 62–72, 2008. View at Google Scholar · View at Scopus
  186. H. R. Turnquist, J. Cardinal, C. Macedo et al., “mTOR and GSK-3 shape the CD4+ T-cell stimulatory and differentiation capacity of myeloid DCs after exposure to LPS,” Blood, vol. 115, no. 23, pp. 4758–4769, 2010. View at Publisher · View at Google Scholar · View at Scopus
  187. M. Naranjo-Gomez, D. Raïch-Regué, C. Oñate et al., “Comparative study of clinical grade human tolerogenic dendritic cells,” Journal of Translational Medicine, vol. 9, article 89, 2011. View at Google Scholar
  188. T. Matsumoto, H. Hasegawa, S. Onishi, J. Ishizaki, K. Suemori, and M. Yasukawa, “Protein kinase C inhibitor generates stable human tolerogenic dendritic cells,” Journal of Immunology, vol. 191, no. 5, pp. 2247–2257, 2013. View at Google Scholar
  189. A. Moreau, M. Hill, P. Thébault et al., “Tolerogenic dendritic cells actively inhibit T cells through heme oxygenase-1 in rodents and in nonhuman primates,” FASEB Journal, vol. 23, no. 9, pp. 3070–3077, 2009. View at Publisher · View at Google Scholar · View at Scopus
  190. S. Chitta, L. Santambrogio, and L. J. Stern, “GMCSF in the absence of other cytokines sustains human dendritic cell precursors with T cell regulatory activity and capacity to differentiate into functional dendritic cells,” Immunology Letters, vol. 116, no. 1, pp. 41–54, 2008. View at Publisher · View at Google Scholar · View at Scopus
  191. L. Lu, W. Li, C. Zhong et al., “Increased apoptosis of immunoreactive host cells and augmented donor leukocyte chimerism, not sustained inhibition of B7 molecule expression are associated with prolonged cardiac allograft survival in mice preconditioned with immature donor dendritic cells plus anti-CD40L mAb,” Transplantation, vol. 68, no. 6, pp. 747–757, 1999. View at Publisher · View at Google Scholar · View at Scopus
  192. Q. Wang, M. Zhang, G. Ding et al., “Anti-ICAM-1 antibody and CTLA-4Ig synergistically enhance immature dendritic cells to induce donor-specific immune tolerance in vivo,” Immunology Letters, vol. 90, no. 1, pp. 33–42, 2003. View at Publisher · View at Google Scholar · View at Scopus
  193. Z. Wang, A. E. Morelli, H. Hackstein, K. Kaneko, and A. W. Thomson, “Marked inhibition of transplant vascular sclerosis by in vivo-mobilized donor dendritic cells and anti-CD154 mAb,” Transplantation, vol. 76, no. 3, pp. 562–571, 2003. View at Publisher · View at Google Scholar · View at Scopus
  194. O. Azhipa, K. Kimizuka, A. Nakao et al., “Comparative analysis of the fate of donor dendritic cells and B cells and their influence on alloreactive T cell responses under tacrolimus immunosuppression,” Clinical Immunology, vol. 114, no. 2, pp. 199–209, 2005. View at Publisher · View at Google Scholar · View at Scopus
  195. A. Imai, H. Sahara, Y. Tamura et al., “Inhibition of endogenous MHC class II-restricted antigen presentation by tacrolimus (FK506) via FKBP51,” European Journal of Immunology, vol. 37, no. 7, pp. 1730–1738, 2007. View at Publisher · View at Google Scholar · View at Scopus
  196. C. Voigtländer, S. Rößner, E. Cierpka et al., “Dendritic cells matured with TNF can be further activated in vitro and after subcutaneous injection in vivo which converts their tolerogenicity into immunogenicity,” Journal of Immunotherapy, vol. 29, no. 4, pp. 407–415, 2006. View at Publisher · View at Google Scholar · View at Scopus
  197. D.-S. Lim, M.-S. Kang, J.-A. Jeong, and Y.-S. Bae, “Semi-mature DC are immunogenic and not tolerogenic when inoculated at a high dose in collagen-induced arthritis mice,” European Journal of Immunology, vol. 39, no. 5, pp. 1334–1343, 2009. View at Publisher · View at Google Scholar · View at Scopus
  198. A. E. Morelli, A. T. Larregina, R. W. Ganster et al., “Recombinant adenovirus induces maturation of dendritic cells via an NF-κB-dependent pathway,” Journal of Virology, vol. 74, no. 20, pp. 9617–9628, 2000. View at Publisher · View at Google Scholar · View at Scopus
  199. J.-M. Humbert and F. Halary, “Viral and non-viral methods to genetically modify Dendritic cells,” Current Gene Therapy, vol. 12, no. 2, pp. 127–136, 2012. View at Publisher · View at Google Scholar · View at Scopus
  200. D. Rea, D. Laface, B. Hutchins et al., “Recombinant adenovirus-transduced human dendritic cells engineered to secrete interleukin-10 (IL-10) suppress Th1-type responses while selectively activating IL-10-producing CD4+ T cells,” Human Immunology, vol. 65, no. 11, pp. 1344–1355, 2004. View at Publisher · View at Google Scholar · View at Scopus
  201. P. T. H. Coates, R. Krishnan, S. Kireta, J. Johnston, and G. R. Russ, “Human myeloid dendritic cells transduced with an adenoviral interleukin-10 gene construct inhibit human skin graft rejection in humanized NOD-scid chimeric mice,” Gene Therapy, vol. 8, no. 16, pp. 1224–1233, 2001. View at Publisher · View at Google Scholar · View at Scopus
  202. T. Takayama, H. Tahara, and A. W. Thomson, “Differential effects of myeloid dendritic cells retrovirally transduced to express mammalian or viral interleukin-10 on cytotoxic T lymphocyte and natural killer cell functions and resistance to tumor growth,” Transplantation, vol. 71, no. 9, pp. 1334–1340, 2001. View at Google Scholar · View at Scopus
  203. W.-C. Lee, C. Zhong, S. Qian et al., “Phenotype, function, and in vivo migration and survival of allogeneic dendritic cell progenitors genetically engineered to express TGF-β,” Transplantation, vol. 66, no. 12, pp. 1810–1817, 1998. View at Publisher · View at Google Scholar · View at Scopus
  204. T. Takayama, K. Kaneko, A. E. Morelli, W. Li, H. Tahara, and A. W. Thomson, “Retroviral delivery of transforming growth factor-β1 to myeloid dendritic cells: inhibition of T-cell priming ability and influence on allograft survival,” Transplantation, vol. 74, no. 1, pp. 112–119, 2002. View at Google Scholar · View at Scopus
  205. C. Asiedu, S. S. Dong, A. Pereboev et al., “Rhesus monocyte-derived dendritic cells modified to over-express TGF-β1 exhibit potent veto activity,” Transplantation, vol. 74, no. 5, pp. 629–637, 2002. View at Google Scholar · View at Scopus
  206. S. Buonocore, S. Van Meirvenne, F.-X. Demoor et al., “Dendritic cells transduced with viral interleukin 10 or Fas ligand: no evidence for induction of allotolerance in vivo,” Transplantation, vol. 73, no. 1, pp. S27–S30, 2002. View at Google Scholar · View at Scopus
  207. W.-C. Lee, S. Qiani, Y. Wan et al., “Contrasting effects of myeloid dendritic cells transduced with an adenoviral vector encoding interleukin-10 on organ allograft and tumour rejection,” Immunology, vol. 101, no. 2, pp. 233–241, 2000. View at Publisher · View at Google Scholar · View at Scopus
  208. K. Kaneko, Z. Wang, S. H. Kim, A. E. Morelli, P. D. Robbins, and A. W. Thomson, “Dendritic cells genetically engineered to express IL-4 exhibit enhanced IL-12p70 production in response to CD40 ligation and accelerate organ allograft rejection,” Gene Therapy, vol. 10, no. 2, pp. 143–152, 2003. View at Publisher · View at Google Scholar · View at Scopus
  209. J. Li, A. Meinhardt, M.-E. Roehrich et al., “Indoleamine 2,3-dioxygenase gene transfer prolongs cardiac allograft survival,” American Journal of Physiology, vol. 293, no. 6, pp. H3415–H3423, 2007. View at Publisher · View at Google Scholar · View at Scopus
  210. C. A. Bonham, L. Peng, X. Liang et al., “Marked prolongation of cardiac allograft survival by dendritic cells genetically engineered with NF-κB oligodeoxyribonucleotide decoys and adenoviral vectors encoding CTLA4-Ig,” Journal of Immunology, vol. 169, no. 6, pp. 3382–3391, 2002. View at Google Scholar · View at Scopus
  211. L. Lu, A. Gambotto, W.-C. Lee et al., “Adenoviral delivery of CTLA4lg into myeloid dendritic cells promotes their in vitro tolerogenicity and survival in allogeneic recipients,” Gene Therapy, vol. 6, no. 4, pp. 554–563, 1999. View at Publisher · View at Google Scholar · View at Scopus
  212. T. Takayama, A. E. Morelli, P. D. Robbins, H. Tahara, and A. W. Thomson, “Feasibility of CTLA4lg gene delivery and expression in vivo using retrovirally transduced myeloid dendritic cells that induce alloantigen-specific T cell anergy in vitro,” Gene Therapy, vol. 7, no. 15, pp. 1265–1273, 2000. View at Google Scholar · View at Scopus
  213. R. W. O'Rourke, S.-M. Kang, J. A. Lower et al., “A dendritic cell line genetically modified to express CTLA4-Ig as a means to prolong islet allograft survival,” Transplantation, vol. 69, no. 7, pp. 1440–1446, 2000. View at Google Scholar · View at Scopus
  214. W. Sun, Q. Wang, L. Zhang et al., “Blockade of CD40 pathway enhances the induction of immune tolerance by immature dendritic cells genetically modified to express cytotoxic T lymphocyte antigen 4 immunoglobulin,” Transplantation, vol. 76, no. 9, pp. 1351–1359, 2003. View at Publisher · View at Google Scholar · View at Scopus
  215. H. Matsue, K. Matsue, M. Walters, K. Okumura, H. Yagita, and A. Takashima, “Induction of antigen-specific immunosuppression by CD95L cDNA- transfected 'killer' dendritic cells,” Nature Medicine, vol. 5, no. 8, pp. 930–937, 1999. View at Publisher · View at Google Scholar · View at Scopus
  216. W.-P. Min, R. Gorczynski, X.-Y. Huang et al., “Dendritic cells genetically engineered to express Fas ligand induce donor-specific hyporesponsiveness and prolong allograft survival,” Journal of Immunology, vol. 164, no. 1, pp. 161–167, 2000. View at Google Scholar · View at Scopus
  217. S. Buonocore, F. Paulart, A. Le Moine et al., “Dendritic cells overexpressing CD95 (Fas) ligand elicit vigorous allospecific T-cell responses in vivo,” Blood, vol. 101, no. 4, pp. 1469–1476, 2003. View at Publisher · View at Google Scholar · View at Scopus
  218. S. Buonocore, V. Flamand, N. Claessen, P. Heeringa, M. Goldman, and S. Florquin, “Dendritic cells overexpressing Fas-ligand induce pulmonary vasculitis in mice,” Clinical and Experimental Immunology, vol. 137, no. 1, pp. 74–80, 2004. View at Publisher · View at Google Scholar · View at Scopus
  219. J. Machen, J. Harnaha, R. Lakomy, A. Styche, M. Trucco, and N. Giannoukakis, “Antisense oligonucleotides down-regulating costimulation confer diabetes-preventive properties to nonobese diabetic mouse dendritic cells,” Journal of Immunology, vol. 173, no. 7, pp. 4331–4341, 2004. View at Google Scholar · View at Scopus
  220. X. Liang, L. Lu, Z. Chen et al., “Administration of dendritic cells transduced with antisense oligodeoxyribonucleotides targeting CD80 or CD86 prolongs allograft survival,” Transplantation, vol. 76, no. 4, pp. 721–729, 2003. View at Publisher · View at Google Scholar · View at Scopus
  221. Q. Wang, Y. Liu, J. Wang et al., “Induction of allospecific tolerance by immature dendritic cells genetically modified to express soluble TNF receptor,” Journal of Immunology, vol. 177, no. 4, pp. 2175–2185, 2006. View at Google Scholar · View at Scopus
  222. K. R. Garrod, C. K. Chang, F.-C. Liu, T. V. Brennan, R. D. Foster, and S.-M. Kang, “Targeted lymphoid homing of dendritic cells is required for prolongation of allograft survival,” Journal of Immunology, vol. 177, no. 2, pp. 863–868, 2006. View at Google Scholar · View at Scopus
  223. M. J. Perone, S. Bertera, Z. S. Tawadrous et al., “Dendritic cells expressing transgenic galectin-1 delay onset of autoimmune diabetes in mice,” Journal of Immunology, vol. 177, no. 8, pp. 5278–5289, 2006. View at Google Scholar · View at Scopus
  224. D. Cooper, J. M. Ilarregui, S. A. Pesoa, D. O. Croci, M. Perretti, and G. A. Rabinovich, “Multiple functional targets of the immunoregulatory activity of Galectin-1. Control of immune cell trafficking, dendritic cell physiology, and T-cell fate,” Methods in Enzymology, vol. 480, pp. 199–244, 2010. View at Publisher · View at Google Scholar · View at Scopus
  225. A. E. Morelli and A. W. Thomson, “Galectin-1, immune regulation and liver allograft survival,” American Journal of Transplantation, vol. 13, no. 3, pp. 535–536, 2013. View at Google Scholar
  226. J. M. Ilarregui, D. O. Croci, G. A. Bianco et al., “Tolerogenic signals delivered by dendritic cells to T cells through a galectin-1-driven immunoregulatory circuit involving interleukin 27 and interleukin 10,” Nature Immunology, vol. 10, no. 9, pp. 981–991, 2009. View at Publisher · View at Google Scholar · View at Scopus
  227. P.-L. Kuo, J.-Y. Hung, S.-K. Huang et al., “Lung cancer-derived galectin-1 mediates dendritic cell anergy through inhibitor of DNA binding 3/IL-10 signaling pathway,” Journal of Immunology, vol. 186, no. 3, pp. 1521–1530, 2011. View at Publisher · View at Google Scholar · View at Scopus
  228. A. Mobergslien and M. Sioud, “Galectin-1 and -3 gene silencing in immature and mature dendritic cells enhances T cell activation and interferon-γ production,” Journal of Leukocyte Biology, vol. 91, no. 3, pp. 461–467, 2012. View at Publisher · View at Google Scholar · View at Scopus
  229. Y. Ye, S. Yan, G. Jiang et al., “Galectin-1 prolongs survival of mouse liver allografts from Flt3L-pretreated donors,” American Journal of Transplantation, vol. 13, no. 3, pp. 569–579, 2013. View at Google Scholar
  230. A. Moreau, A. Noble, K. Ratnasothy et al., “Absence of Galectin-1 accelerates CD8+ T cell-mediated graft rejection,” European Journal of Immunology, vol. 42, no. 11, pp. 2881–2888, 2012. View at Google Scholar
  231. A. E. Morelli, “The immune regulatory effect of apoptotic cells and exosomes on dendritic cells: its impact on transplantation,” American Journal of Transplantation, vol. 6, no. 2, pp. 254–261, 2006. View at Publisher · View at Google Scholar · View at Scopus
  232. A. E. Morelli and A. T. Larregina, “Apoptotic cell-based therapies against transplant rejection: role of recipient's dendritic cells,” Apoptosis, vol. 15, no. 9, pp. 1083–1097, 2010. View at Publisher · View at Google Scholar · View at Scopus
  233. T. H. Lee, E. D'Asti, N. Magnus, K. Al-Nedawi, B. Meehan, and J. Rak, “Microvesicles as mediators of intercellular communication in cancer—the emerging science of cellular 'debris',” Seminars in Immunopathology, vol. 33, no. 5, pp. 455–467, 2011. View at Google Scholar · View at Scopus
  234. Z. Wang, W. J. Shufesky, A. Montecalvo, S. J. Divito, A. T. Larregina, and A. E. Morelli, “In situ-targeting of dendritic cells with donor-derived apoptopic cells restrains indirect allorecognition and ameliorates allograft vasculopathy,” PLoS ONE, vol. 4, no. 3, Article ID e4940, 2009. View at Publisher · View at Google Scholar · View at Scopus
  235. M. Garrovillo, A. Ali, H. A. Depaz et al., “Induction of transplant tolerance with immunodominant allopeptide-pulsed host lymphoid and myeloid dendritic cells,” American Journal of Transplantation, vol. 1, no. 2, pp. 129–137, 2001. View at Google Scholar · View at Scopus
  236. T. Taner, H. Hackstein, Z. Wang, A. E. Morelli, and A. W. Thomson, “Rapamycin-treated, alloantigen-pulsed host dendritic cells induce Ag-specific T cell regulation and prolong graft survival,” American Journal of Transplantation, vol. 5, no. 2, pp. 228–236, 2005. View at Publisher · View at Google Scholar · View at Scopus
  237. P. Correale, G. Campoccia, K. Y. Tsang et al., “Recruitment of dendritic cells and enhanced antigen-specific immune reactivity in cancer patients treated with hr-GM-CSF (Molgramostim) and hr-IL-2: results from a phase Ib clinical trial,” European Journal of Cancer, vol. 37, no. 7, pp. 892–902, 2001. View at Publisher · View at Google Scholar · View at Scopus
  238. B. G. Redman, A. E. C. Alfred E. Chang, J. W. Joel Whitfield et al., “Phase Ib trial assessing autologous, tumor-pulsed dendritic cells as a vaccine administered with or without IL-2 in patients with metastatic melanoma,” Journal of Immunotherapy, vol. 31, no. 6, pp. 591–598, 2008. View at Publisher · View at Google Scholar · View at Scopus
  239. M. V. Dhodapkar and R. M. Steinman, “Antigen-bearing immature dendritic cells induce peptide-specific CD8+ regulatory T cells in vivo in humans,” Blood, vol. 100, no. 1, pp. 174–177, 2002. View at Publisher · View at Google Scholar · View at Scopus
  240. R. Thomas, S. Street, N. Ramnoruth et al., “Safety and preliminary evidence of efficacy in a phase I clinical trial of autologous tolerising dendritic cells exposed to citrullinated peptides (Rheumavax) in patients with rheumatoid arthritis,” Annals of the Rheumatic Diseases, vol. 70, supplement 3, article 169, 2011. View at Google Scholar
  241. A. Moreau, E. Varey, G. Bériou et al., “Tolerogenic dendritic cells and negative vaccination in transplantation: from rodents to clinical trials,” Frontiers in Immunology, vol. 3, article 218, 2012. View at Google Scholar
  242. P. M. Emmer, J. Van Der Vlag, G. J. Adema, and L. B. Hilbrands, “Dendritic cells activated by lipopolysaccharide after dexamethasone treatment induce donor-specific allograft hyporesponsiveness,” Transplantation, vol. 81, no. 10, pp. 1451–1459, 2006. View at Publisher · View at Google Scholar · View at Scopus
  243. G. Yu, X. Xu, D. V. Minh, E. D. Kilpatrick, and C. L. Xian, “NK cells promote transplant tolerance by killing donor antigen-presenting cells,” Journal of Experimental Medicine, vol. 203, no. 8, pp. 1851–1858, 2006. View at Publisher · View at Google Scholar · View at Scopus